Ghost Tree Capital, LLC - Q1 2014 holdings

Add to watchlist

$163 Million is the total value of Ghost Tree Capital, LLC's 62 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 111.3% .

All

			Value		Shares		↓ Weighting
	New	ISHARESput	$17,451,000	–	150,000	+100.0%	10.36%	–
	New	MERCK & CO INC NEWcall	$14,193,000	–	250,000	+100.0%	8.43%	–
	Buy	TEVA PHARMACEUTICAL INDS LTDcall	$7,926,000	+97.8%	150,000	+50.0%	4.71%	+90.8%
		GILEAD SCIENCES INCcall	$7,086,000	-5.6%	100,000	0.0%	4.21%	-8.9%
	New	BRISTOL MYERS SQUIBB COcall	$5,195,000	–	100,000	+100.0%	3.08%	–
	New	MYLAN INCcall	$4,883,000	–	100,000	+100.0%	2.90%	–
	New	AEGERION PHARMACEUTICALS INCcall	$4,618,000	–	100,000	+100.0%	2.74%	–
		VERTEX PHARMACEUTICALS INCcall	$4,597,000	-4.8%	65,000	0.0%	2.73%	-8.2%
PRTA	Sell	PROTHENA CORP PLC	$4,214,000	+22.2%	110,000	-15.4%	2.50%	+18.0%
BMY	Sell	BRISTOL MYERS SQUIBB CO	$4,156,000	-21.8%	80,000	-20.0%	2.47%	-24.5%
FLML	Buy	FLAMEL TECHNOLOGIES SAsponsored adr	$4,020,000	+316.1%	300,000	+150.0%	2.39%	+301.9%
ARAY	Sell	ACCURAY INC	$3,840,000	-1.9%	400,018	-11.1%	2.28%	-5.4%
	New	INSMED INCcall	$3,808,000	–	200,000	+100.0%	2.26%	–
AMAG	New	AMAG PHARMACEUTICALS INC	$3,716,000	–	192,057	+100.0%	2.21%	–
CHTP	Buy	CHELSEA THERAPEUTICS INTL LT	$3,312,000	+645.9%	600,000	+500.0%	1.97%	+620.1%
UNIS	Buy	UNILIFE CORP NEW	$3,256,000	+111.4%	800,000	+128.6%	1.93%	+104.1%
CYH	Buy	COMMUNITY HEALTH SYS INC NEW	$3,134,000	+14.0%	80,000	+14.3%	1.86%	+10.1%
ARWR	Sell	ARROWHEAD RESH CORP	$3,038,000	+1.8%	185,000	-32.7%	1.80%	-1.7%
	New	AFFYMETRIX INCnote 4.000% 7/0	$3,030,000	–	425,000	+100.0%	1.80%	–
TRNX	Buy	TORNIER N V	$2,759,000	+46.8%	130,000	+30.0%	1.64%	+41.7%
ICPT	New	INTERCEPT PHARMACEUTICALS IN	$2,638,000	–	8,000	+100.0%	1.57%	–
INSM	Sell	INSMED INC	$2,570,000	-24.4%	135,000	-32.5%	1.53%	-27.1%
TNDM	Buy	TANDEM DIABETES CARE INC	$2,540,000	+119.0%	115,000	+155.6%	1.51%	+111.2%
MMSI	New	MERIT MED SYS INC	$2,503,000	–	175,000	+100.0%	1.49%	–
OCRX	Buy	OCERA THERAPEUTICS INC	$2,479,000	+154.5%	235,000	+213.3%	1.47%	+145.7%
FURX	New	FURIEX PHARMACEUTICALS INC	$2,393,000	–	27,500	+100.0%	1.42%	–
EW	New	EDWARDS LIFESCIENCES CORP	$2,225,000	–	30,000	+100.0%	1.32%	–
ISRG	New	INTUITIVE SURGICAL INC	$2,190,000	–	5,000	+100.0%	1.30%	–
BRKR	Sell	BRUKER CORP	$2,051,000	-9.8%	90,000	-21.7%	1.22%	-12.9%
BIIB	Sell	BIOGEN IDEC INC	$1,979,000	-55.8%	6,471	-59.6%	1.18%	-57.3%
HZNP	Buy	HORIZON PHARMA INC	$1,966,000	+158.0%	130,000	+30.0%	1.17%	+148.8%
ALGN	New	ALIGN TECHNOLOGY INC	$1,813,000	–	35,000	+100.0%	1.08%	–
DYAX	Sell	DYAX CORP	$1,796,000	-47.0%	200,000	-55.6%	1.07%	-48.9%
CNAT	New	CONATUS PHARMACEUTICALS INC	$1,790,000	–	219,977	+100.0%	1.06%	–
	New	CHELSEA THERAPEUTICS INTL LTcall	$1,656,000	–	300,000	+100.0%	0.98%	–
ATRC	New	ATRICURE INC	$1,599,000	–	85,000	+100.0%	0.95%	–
SGMO	Sell	SANGAMO BIOSCIENCES INC	$1,566,000	-24.9%	86,606	-42.3%	0.93%	-27.5%
NSTG	New	NANOSTRING TECHNOLOGIES INC	$1,549,000	–	75,000	+100.0%	0.92%	–
SPNC	Sell	SPECTRANETICS CORP	$1,516,000	-65.3%	50,000	-71.4%	0.90%	-66.6%
ILMN	New	ILLUMINA INC	$1,487,000	–	10,000	+100.0%	0.88%	–
GWPH	New	GW PHARMACEUTICALS PLCads	$1,484,000	–	25,000	+100.0%	0.88%	–
DEPO	Buy	DEPOMED INC	$1,450,000	+174.1%	100,000	+100.0%	0.86%	+164.9%
LCI	Sell	LANNET INC	$1,429,000	-28.0%	40,000	-33.3%	0.85%	-30.6%
ENTA	New	ENANTA PHARMACEUTICALS INC	$1,400,000	–	35,000	+100.0%	0.83%	–
TXMD	New	THERAPEUTICSMD INC	$1,262,000	–	200,000	+100.0%	0.75%	–
PBYI	Sell	PUMA BIOTECHNOLOGY INC	$1,180,000	-54.4%	11,330	-54.7%	0.70%	-56.0%
NUVA	New	NUVASIVE INC	$1,152,000	–	30,000	+100.0%	0.68%	–
EPZM	New	EPIZYME INC	$1,025,000	–	45,000	+100.0%	0.61%	–
KYTH	New	KYTHERA BIOPHARMACEUTICALS I	$994,000	–	25,000	+100.0%	0.59%	–
ATRS	New	ANTARES PHARMA INC	$875,000	–	250,000	+100.0%	0.52%	–
TEAR	Sell	TEARLAB CORP	$845,000	-48.3%	125,000	-28.6%	0.50%	-50.1%
NXTM	Sell	NXSTAGE MEDICAL INC	$796,000	-36.3%	62,500	-50.0%	0.47%	-38.5%
ETRM	New	ENTEROMEDICS INC	$728,000	–	400,000	+100.0%	0.43%	–
BIOL	New	BIOLASE INC	$723,000	–	300,000	+100.0%	0.43%	–
FLXN	New	FLEXION THERAPEUTICS INC	$658,000	–	40,000	+100.0%	0.39%	–
RVNC	New	REVANCE THERAPEUTICS INC	$630,000	–	20,000	+100.0%	0.37%	–
AMRN	New	AMARIN CORP PLCspons adr new	$543,000	–	300,000	+100.0%	0.32%	–
NVAX	New	NOVAVAX INC	$453,000	–	100,000	+100.0%	0.27%	–
CPRX	Buy	CATALYST PHARM PARTNERS INC	$452,000	+32.6%	200,000	+14.3%	0.27%	+27.6%
DVAX	Sell	DYNAVAX TECHNOLOGIES CORP	$447,000	-34.8%	247,340	-29.3%	0.26%	-37.2%
ANAC	New	ANACOR PHARMACEUTICALS INC	$400,000	–	20,000	+100.0%	0.24%	–
SRNE	New	SORRENTO THERAPEUTICS INC	$385,000	–	30,000	+100.0%	0.23%	–
DRRX	New	DURECT CORP	$333,000	–	250,000	+100.0%	0.20%	–
RXDX	New	IGNYTA INC	$195,000	–	23,500	+100.0%	0.12%	–
WMGIZ		WRIGHT MED GROUP INCright 03/01/2019	$46,000	+155.6%	55,150	0.0%	0.03%	+145.5%
DSCO	Exit	DISCOVERY LABORATORIES INC N	$0	–	-100,000	-100.0%	-0.14%	–
OPHT	Exit	OPHTHOTECH CORP	$0	–	-20,000	-100.0%	-0.40%	–
A	Exit	AGILENT TECHNOLOGIES INC	$0	–	-15,000	-100.0%	-0.53%	–
ELGX	Exit	ENDOLOGIX INC	$0	–	-50,000	-100.0%	-0.54%	–
ARIA	Exit	ARIAD PHARMACEUTICALS INC	$0	–	-130,000	-100.0%	-0.55%	–
NSPH	Exit	NANOSPHERE INC	$0	–	-400,000	-100.0%	-0.56%	–
BEAT	Exit	BIOTELEMETRY INC	$0	–	-125,000	-100.0%	-0.61%	–
MASI	Exit	MASIMO CORP	$0	–	-35,000	-100.0%	-0.63%	–
GERN	Exit	GERON CORP	$0	–	-235,000	-100.0%	-0.68%	–
AIRM	Exit	AIR METHODS CORP	$0	–	-20,000	-100.0%	-0.72%	–
OSUR	Exit	ORASURE TECHNOLOGIES INC	$0	–	-200,000	-100.0%	-0.77%	–
JAZZ	Exit	JAZZ PHARMACEUTICALS PLC	$0	–	-10,000	-100.0%	-0.78%	–
BMRN	Exit	BIOMARIN PHARMACEUTICAL INC	$0	–	-20,000	-100.0%	-0.87%	–
HOLX	Exit	HOLOGIC INC	$0	–	-65,000	-100.0%	-0.89%	–
CELG	Exit	CELGENE CORP	$0	–	-10,000	-100.0%	-1.04%	–
CLVS	Exit	CLOVIS ONCOLOGY INC	$0	–	-30,000	-100.0%	-1.11%	–
5100PS	Exit	VOLCANO CORPORATION	$0	–	-85,000	-100.0%	-1.14%	–
	Exit	AUXILIUM PHARMACEUTICALS INCcall	$0	–	-100,000	-100.0%	-1.28%	–
	Exit	HOLOGIC INCcall	$0	–	-100,000	-100.0%	-1.38%	–
GNMK	Exit	GENMARK DIAGNOSTICS INC	$0	–	-190,000	-100.0%	-1.55%	–
SGNT	Exit	SAGENT PHARMACEUTICALS INC	$0	–	-100,000	-100.0%	-1.56%	–
IDRA	Exit	IDERA PHARMACEUTICALS INC	$0	–	-550,000	-100.0%	-1.57%	–
QDEL	Exit	QUIDEL CORP	$0	–	-85,000	-100.0%	-1.62%	–
ZBH	Exit	ZIMMER HLDGS INC	$0	–	-35,000	-100.0%	-2.01%	–
HTWR	Exit	HEARTWARE INTL INC	$0	–	-35,600	-100.0%	-2.06%	–
MZOR	Exit	MAZOR ROBOTICS LTDsponsored ads	$0	–	-175,000	-100.0%	-2.10%	–
CBST	Exit	CUBIST PHARMACEUTICALS INC	$0	–	-50,000	-100.0%	-2.12%	–
	Exit	THORATEC CORPcall	$0	–	-100,000	-100.0%	-2.25%	–
	Exit	GILEAD SCIENCES INCput	$0	–	-750,000	-100.0%	-3.47%	–
	Exit	NUVASIVE INCcall	$0	–	-200,000	-100.0%	-3.98%	–
	Exit	EDWARDS LIFESCIENCES CORPcall	$0	–	-100,000	-100.0%	-4.05%	–
GILD	Exit	GILEAD SCIENCES INC	$0	–	-135,000	-100.0%	-6.24%	–
	Exit	ALLERGAN INCcall	$0	–	-100,000	-100.0%	-6.83%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2014-05-15

Signatures

The EDGAR filing(s) were signed by:

David Kim — Managing Member

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
MIRATI THERAPEUTICS INC	30	Q3 2023	7.3%
ASCENDIS PHARMA A/S - ADR	28	Q3 2023	11.8%
BIOCRYST PHARMACEUTICALS INC	25	Q2 2023	2.4%
AMICUS THERAPEUTICS INC	23	Q3 2023	5.6%
SAREPTA THERAPEUTICS INC	22	Q3 2023	9.1%
SPDR SER TR	20	Q3 2022	16.9%
IOVANCE BIOTHERAPEUTICS INC	18	Q2 2023	5.5%
ROCKET PHARMACEUTICALS INC	18	Q2 2023	6.1%
SAGE THERAPEUTICS INC	18	Q1 2021	4.8%
IMMUNOMEDICS INC	17	Q2 2020	8.7%

View Ghost Tree Capital, LLC's complete holdings history.

Latest filings

Type	Filed
13F-HR	2024-02-14
13F-HR	2023-11-14
13F-HR	2023-08-14
13F-HR	2023-05-15
13F-HR	2023-02-14
13F-HR	2022-11-14
13F-HR	2022-08-15
13F-HR	2022-05-16
13F-HR	2022-02-16
13F-HR	2021-11-15

View Ghost Tree Capital, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (162544000.0 != 168423000.0)
The reported number of holdings is incorrect (62 != 65)

Export Ghost Tree Capital, LLC's holdings